glp-1 agonists and retained gastric contents at endoscopy Glucagon-like peptide-1 receptor agonist use the risk of residual and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis glp-1 agonists and retained gastric

Yudkoff, M

The relative contributions of the direct effects of incretin receptor agonists on fibrosis versus the secondary effects of weight loss and systemic reductions in inflammation remain to be delineated

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months

Most notably, the highest dose of retatrutide (12 mg) led to 24.2% weight loss (vs 2.1% with placebo) at 48 weeks

Helps prevent obesity If the body is low on glutathione, the environmental toxins will metabolize in the fat tissues, which means the body will hold onto excess weight, says Dr

Monitor for hypoglycemia symptoms, particularly if taking concurrent insulin or sulfonylureas